... Predictive factors for nonstandard treatment decisions in head and neck cancer treatment differed between the treating physician and the patient Patients who received nonstandard treatment had a lower ... decline standard, curative treatment modalities Our objective is to determine factors associated with noncompliance in head and neck cancer treatment for both patients and physicians and to assess ... low and treatments are associated with morbidity and mortality as well Head and neck squamous cell carcinoma (HNSCC) describe a range of squamous cell tumors that arise from the head and neck
Ngày tải lên: 28/09/2020, 10:03
... swallowing interventions, and to explore any relationships between these strategies and intervention effects Randomised and quasi-randomised studies of head and neck cancer patients were included ... treated for head and neck cancer (HNC) [1], arise both from the presence of a tumour, and as a con-sequence of its treatment [2] Dysphagia is a major patient concern after cancer treatment due ... characteristics (diagnostic and treatment group, sample size, age range, gender and baseline swallow function), treatment (information about the type of treatment and comparator groups), and outcome measures
Ngày tải lên: 20/09/2020, 01:02
Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
... Trang 1R E S E A R C H A R T I C L E Open AccessTreatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer Markus Hecht1* , Dennis Hahn2, Philipp Wolber3, ... Große-Thie11, Orlando Guntinas-Lichius12, Jens von der Grün13, Panagiotis Balermpas13, Katrin Orlowski14, Diethelm Messinger15, Karsten G Stenzel14and Rainer Fietkau1 Abstract Background: Head and neck squamous ... metastatic head and neck squamous cell carcinoma (HNSCC) still have a poor prognosis In the last decade many of these patients were treated with palliative chemotherapy with platinum, 5-flurouracil and
Ngày tải lên: 05/11/2020, 08:21
Tài liệu Diagnosis and management of head and neck cancer docx
... RECURRENT HEAD AND NECK CANCER There is no consistent evidence that surveillance with cross-sectional imaging alters outcome following treatment for head and neck cancer 3 ReFeRRAL AND DIAGNOsIs ... public awareness of head and neck cancer is low.39-43 A randomised controlled trial found that patients attending primary care who had read an information leaflet about head and neck cancer had increased awareness of risk compared to patients who had not seen the leaflet ... 15 Overview of treatment of the primary tumour and neck 126 Treatment: radiotherapy as the major treatment modality 17 7 Treatment: surgery as the major treatment modality 22 8 Treatment: chemotherapy
Ngày tải lên: 14/02/2014, 22:20
Báo cáo khoa học: "Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients" ppsx
... therapy for head and neck carcinoma. The Oncologist 2007, 12:555-564. 2. Lee N, Puri D, Blanco AI, Chao KS: Intensity modulated radiathion therapy in head and neck cancers: an update. Head and Neck ... advanced head and neck cancers is feasible and effective, with acceptable toxicities. Introduction Radiotherapy (RT), with or without chemotherapy, is the primary treatment modality for head and neck ... radiation therapy of head and neck cancer. Expert Rev Anticancer Ther 2008, 8:633-644. 4. Li Y, Ten Haken R, Eisbruch A: The impact of dose on parotid recovery in head and neck cancer patients treated
Ngày tải lên: 09/08/2014, 09:20
Báo cáo khoa học: "Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy" pdf
... pattern of treat-ment failure and the most common cause of death in head and neck cancer patients [1] As most recurrences occur in the first 2 years after primary treatment and 80% arise in previously ... patients with recurrent and second primary tumors, limited and advanced tumors, curative and palliative treatment, squamous cell carcinoma and other histologies, and variable treatment strategies ... Radiotherapy for Locally Recurrent Head-and-Neck Tumors Int J Radiat Oncol Biol Phys 14 Langlois D, Eschwege F, Kramar A, Richard JM: Reirradiation of the head and neck cancers Radiother Oncol 1985,
Ngày tải lên: 09/08/2014, 09:21
Báo cáo khoa học: "Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life" doc
... Amsterdam, The Netherlands, 3 Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands, 4 Department of ... Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands and 5 Department of ORL, Academic Medical Center, Amsterdam, the Netherlands, Department of Head and Neck ... glands was removed in 53% of the cases, both submandibular glands in 12%, 6% had their superficial parotid gland removed another 6% had their superficial parotid gland and one submandibular gland
Ngày tải lên: 09/08/2014, 09:22
Báo cáo khoa học: " Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy" pdf
... for head and neck carcinoma Oncologist 2007, 12:565-8. 5. Rosenthal DI, Lewin JS, Eisbruch A: Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer ... with head and neck cancer Head Neck 2000, 22:474-82. 37 Stenson KM, MacCracken E, List M, Haraf DJ, Brockstein B, Weich-selbaum R, Vokes EE: Swallowing function in patients with head and neck cancer ... Newman LA, Liu D: Site of disease and treatment protocol as correlated of swal-lowing function in patients with head and neck cancer treated with chemoradiaiton Head Neck 2006, 28:64-73. 31 Langendijk
Ngày tải lên: 09/08/2014, 10:20
Báo cáo khoa học: " IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients" pps
... simultaneously integrated boost (SIB) in head and neck cancer patients Address: 1 Department of Radiation Oncology, University Hospital, Zurich, Switzerland and 2 Department of Radiation Physics, ... boost (SIB) application in the head and neck region in terms of normal tissue response As known from 3DCRT, dose, fractionation and treated volumes are the tumor control and normal tissue tolerance ... (H-0022 and 0225)) have been pub-lished; to this date there is no universally agreed standard of dosage We found SIB 2.11 and SIB2.2 equally well tolerated and safe with respect to acute and late
Ngày tải lên: 09/08/2014, 10:20
Báo cáo y học: "Systems biology-defined NF-κB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status" pps
... angiogenesis, immune and proinflammatory responses, and therapeutic resistance in head and neck squa- mous cell carcinoma (HNSCC) and other cancers [3-5]. How- ever, nuclear activation of hetero- and homodimers ... differentially expressed by head and neck cancer cell lines differing in p53 status. There were 748 NF- κ B targets predicted and individually annotated for RELA, NF κ B1 or cREL regulation, and a prevalence ... regulons in 1,265 genes differentially expressed in head and neck cancer cell lines differing in p53 status revealed a cross talk between NFkB and specific signaling pathways.</p> Abstract
Ngày tải lên: 14/08/2014, 08:20
Nanoparticle based targeted therapeutics in head-and-neck cancer
... Multimodal treatment for head and neck cancer Surg Clin North Am 2009; 89: 43-52 Murphy BA, Gilbert J, Ridner SH Systemic and global toxicities of head and neck treatment Expert Rev Anticancer Ther ... smoking in never drinkers, and the risk of head and neck cancer: Pooled analysis in the international head and neck cancer epidemiology consortium Journal Of the National Cancer Institute 2007; 99: ... Squamous Cell Carcinoma Of the Head And Neck as a Target for a Novel Nanotherapeutic Drug Head And Neck-Journal for the Sciences And Specialties Of the Head And Neck 2009; 31: 475-81 113 Wang
Ngày tải lên: 15/01/2020, 16:59
Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin
... cell head and neck cancer J Clin Oncol 2003;21:92 –8. 3 Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al Defining risk levels in locally advanced head and neck cancers: ... patients with head and neck cancer receiving outpatient treatment with concurrent high-dose cisplatin and radiotherapy Am J Clin Oncol 2018;41: 432 –40. 23 Prasaja Y, Sutandyo N, Andrajati R Incidence ... EORTC (#22931) and RTOG (# 9501) Head Neck 2005;27:843 –50. 4 Pignon JP, le Maître A, Maillard E, Bourhis J, MACH-NC Collaborative Group Meta-analysis of chemotherapy in head and neck cancer (MACH-NC):
Ngày tải lên: 17/06/2020, 18:48
Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer
... mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer Sandhya Yadav1, Somnath D Bhagat2, Amit Gupta1, Atul Samaiya3, Aasheesh Srivastava2and Sanjeev Shukla1* ... approach can provide an effective way to modulate cancer-specific-splicing and thereby aid in the treatment of HNC Keywords: Curcumin, Head and neck cancer, PKM, Warburg effect, Alternative splicing ... head-and-neck cancer (HNC) Though both epigenetic alterations [40,41] and aberrant alternative splicing [42,43] are in-dividually associated with the development and pro-gression of various cancers
Ngày tải lên: 17/06/2020, 18:58
Feasibility and acceptability of combining cognitive behavioural therapy techniques with swallowing therapy in head and neck cancer dysphagia
... Research and Treatment of Cancer – Head and Neck module; EORTC-QLQ: European Organization for Research and Treatment of Cancer- Quality of Life Questionnaire; HADS: Hospital Anxiety and Depression ... country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients Eur J Cancer 2000;36(14):1796–807 Chalder T, Berelowitz ... practices in the management of the psycho-oncologic aspects of head and neck cancer patients: recommendations from the European head and neck cancer society make sense campaign Ann Oncol 2014;25(11):2115–24
Ngày tải lên: 23/07/2020, 23:44
New paste for severe stomatitis in patients undergoing head-and-neck cancer radiotherapy and/or chemotherapy with oral appliance
... undergoing treatment by radiotherapy and/or chemotherapy (hereinafter referred to as “CRT”) for cancer in the head and neck region with severe oral stomatitis Radiotherapy for head and neck cancer ... of Medicine 2014;39:25–9 Katou K Nutrition support and oral Care for Head and Neck Cancer Patients Undergoing Chemoradiotherapy Head and Neck Cancer Frontier 2014;2: 48–51 Valente VB, Takamiya ... care, laser treatment and use of mouthwash containing local anesthetic Many of the patients with head and neck cancer are elderly and have postoperative defects of teeth, jaw bone and oral tissue,
Ngày tải lên: 24/07/2020, 01:55
Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy – design of the DAHANCA 31 randomized trial
... Denmark (protocol id: H-15003725) and registered retrospectively at ClinicalTrials.gov (NCT02557529) September 11th 2015 Keywords: Head and neck cancer, Head and neck squamous cell carcinoma, Chemoradiotherapy, ... 31 randomized trial Camilla K Lonkvist1, Simon Lønbro2,3, Anders Vinther4, Bo Zerahn5, Eva Rosenbom6, Hanne Primdahl7, Pernille Hojman8 and Julie Gehl1* Abstract Background: Head and neck cancer ... biological sampling and exploration into cytokines and mechanisms involved The current paper discusses decisions and methods behind exercise in head and neck cancer patients undergoing concomitant chemoradiotherapy
Ngày tải lên: 06/08/2020, 07:25
Regular recreational physical activity and risk of head and neck cancer
... stated Lin et al BMC Cancer (2017) 17:286 Background Head and neck cancer (HNC) (cancers of the oral cavity, oropharynx, hypopharynx, and larynx) is the fifth leading cancer in the world, with ... carcinoma of the head and neck, including cancers of the oral cavity, oropharynx, hypopharynx, and larynx; 2) no history of any type of cancer diagnosis; and 3) between the age of 20 and 80 Controls ... quids per day, and Lin et al BMC Cancer (2017) 17:286 Page of 10 Fig The proposed confounding structure for investigating the relationship between physical activity and head and neck cancer “+” denotes
Ngày tải lên: 19/09/2020, 21:40
Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bioradiotherapy for locally advanced head and neck cancer: A monocentric case control study
... for head and neck cancer Eur J Cancer Care 2010;19:631–5 11 Nguyen NP, Smith HJ, Dutta S, Alfieri A, North D, Nguyen PD, et al Aspiration occurrence during chemoradiation for head and neck cancer ... carcinoma and its clinical and dysphagia-related predictors Head Neck 2014;36:120–5 19 Rathod S, Livergant J, Klein J, Witterick I, Ringash J A systematic review of quality of life in head and neck cancer ... initiation of the treatment Thirty-six (11.8%) patients had coexisting malignancies included multiple primary HNC, esophageal cancer, gastric cancer, prostate cancer, lung cancer, and renal cancer All
Ngày tải lên: 20/09/2020, 01:10
HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation
... Mol Cancer Ther 2017;16(1):25–34 Pignon J-P, le Mtre A, Maillard E, Bourhis J, MACH-NC Collaborative Group Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised ... Christopher M Nutting2,3 and Kevin J Harrington1,2,3 Abstract Background: Concurrent cisplatin radiotherapy (CCRT) is a current standard-of-care for locally advanced head and neck squamous cell carcinoma ... stated McLaughlin et al BMC Cancer (2017) 17:86 Background Concurrent cisplatin radiotherapy (CCRT) is a standardof-care for patients with locally advanced head and neck squamous cell carcinoma
Ngày tải lên: 20/09/2020, 01:18
Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis
... human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer: a systematic review and meta-analysis of trends by time and region Head Neck 2013;35:747 –55. 10 Fakhry C, Westra ... HPV-positive head and neck cancers increases, this may highlight the importance of under-standing the underlying mechanisms responsible for oncogenesis and the differences between HPV-related and HPV-unrelated ... E6/E7 oncogene and p53 function within tumours were associated with the widely reported improved patient survival and prognosis in head and neck cancer Methods: HPV16 DNA, mRNA and p53 mRNA presence
Ngày tải lên: 21/09/2020, 01:35
Bạn có muốn tìm thêm với từ khóa: